MX2023011498A - Toallita topica que contiene nifedipina y lidocaina. - Google Patents
Toallita topica que contiene nifedipina y lidocaina.Info
- Publication number
- MX2023011498A MX2023011498A MX2023011498A MX2023011498A MX2023011498A MX 2023011498 A MX2023011498 A MX 2023011498A MX 2023011498 A MX2023011498 A MX 2023011498A MX 2023011498 A MX2023011498 A MX 2023011498A MX 2023011498 A MX2023011498 A MX 2023011498A
- Authority
- MX
- Mexico
- Prior art keywords
- lidocaine
- wipes containing
- containing nifedipine
- nifedipine
- topical
- Prior art date
Links
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004194 lidocaine Drugs 0.000 title abstract 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001597 nifedipine Drugs 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 206010002153 Anal fissure Diseases 0.000 abstract 1
- 208000016583 Anus disease Diseases 0.000 abstract 1
- 208000009531 Fissure in Ano Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169768P | 2021-04-01 | 2021-04-01 | |
| PCT/US2022/023130 WO2022212892A1 (en) | 2021-04-01 | 2022-04-01 | Topical wipe containing nifedipine and lidocaine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023011498A true MX2023011498A (es) | 2024-01-17 |
Family
ID=83456873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023011498A MX2023011498A (es) | 2021-04-01 | 2022-04-01 | Toallita topica que contiene nifedipina y lidocaina. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240156756A1 (enExample) |
| EP (1) | EP4312984A4 (enExample) |
| JP (1) | JP2024512791A (enExample) |
| CN (1) | CN117377461A (enExample) |
| AU (1) | AU2022252406A1 (enExample) |
| CA (1) | CA3213764A1 (enExample) |
| MX (1) | MX2023011498A (enExample) |
| WO (1) | WO2022212892A1 (enExample) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04124128A (ja) * | 1990-09-13 | 1992-04-24 | Lion Corp | 肛門部疾患治療用貼付剤 |
| JP3012732U (ja) * | 1994-12-20 | 1995-06-27 | 茂郎 槇島 | 痔治療の薬剤保持部材 |
| JP2001170159A (ja) * | 1999-12-19 | 2001-06-26 | Alcare Co Ltd | 緩衝能を有する接皮部材 |
| US20040167479A1 (en) * | 2003-02-20 | 2004-08-26 | The Procter & Gamble Company | Hemorrhoid treatment pad |
| US8377459B2 (en) * | 2003-07-09 | 2013-02-19 | The Procter & Gamble Company | Composition for wet wipes that enhances the efficacy of cleansing while being gentle to the skin |
| WO2014140925A2 (en) * | 2013-03-10 | 2014-09-18 | Peritech Pharma Ltd. | Topical compositions and methods of treatment of topical disorders |
| DK3220924T3 (da) * | 2014-11-17 | 2022-01-03 | Rev Pharma Corp | Lægemiddel til topisk anvendelse til hud- og slimhindeskader i forbindelse med epidermolysis bullosa |
| WO2016118040A1 (ru) * | 2015-01-21 | 2016-07-28 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" | Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий |
| IT201800002413A1 (it) * | 2018-02-05 | 2019-08-05 | Carmine Antropoli | "composizione a base di nifedipina per uso nel trattamento delle ragadi anali e proctalgie" |
| WO2020176004A1 (ru) * | 2019-02-25 | 2020-09-03 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" | Гель для ректального и наружного применения |
-
2022
- 2022-04-01 CN CN202280032680.8A patent/CN117377461A/zh active Pending
- 2022-04-01 AU AU2022252406A patent/AU2022252406A1/en active Pending
- 2022-04-01 WO PCT/US2022/023130 patent/WO2022212892A1/en not_active Ceased
- 2022-04-01 MX MX2023011498A patent/MX2023011498A/es unknown
- 2022-04-01 EP EP22782323.4A patent/EP4312984A4/en active Pending
- 2022-04-01 CA CA3213764A patent/CA3213764A1/en active Pending
- 2022-04-01 JP JP2023561034A patent/JP2024512791A/ja active Pending
-
2023
- 2023-09-29 US US18/375,115 patent/US20240156756A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3213764A1 (en) | 2022-10-06 |
| JP2024512791A (ja) | 2024-03-19 |
| AU2022252406A1 (en) | 2023-11-02 |
| EP4312984A4 (en) | 2025-02-19 |
| WO2022212892A8 (en) | 2023-11-16 |
| EP4312984A1 (en) | 2024-02-07 |
| CN117377461A (zh) | 2024-01-09 |
| WO2022212892A1 (en) | 2022-10-06 |
| US20240156756A1 (en) | 2024-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20220008A1 (ar) | مثبطات parp1 | |
| CL2020000075A1 (es) | Carboxamidas como moduladores de los canales de sodio. | |
| JOP20230073A1 (ar) | بنزاميدات مستبدلة مع 3،1- ثيازول-2- يل | |
| MX2019005379A (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo. | |
| CO2020014217A2 (es) | Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos | |
| CO2020001244A2 (es) | Derivados de quinolina para tratar infecciones con helmintos | |
| MX2020006664A (es) | Composiciones liquidas de suministro. | |
| UY37201A (es) | Nuevos derivados de pirazolopirimidina | |
| EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
| BR112015023922A2 (pt) | composição farmacêutica compreendendo um ativador de ampk e um agente serotonérgico e métodos de uso destes | |
| CL2013000304A1 (es) | Compuestos derivados de 2-arilamino-bencimidazoles inhibidores de prostaglandina e2 (mpges-1); composicion farmaceutica que los comprende; compuestos intermediarios; uso en el tratamiento de enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor. | |
| CL2020001349A1 (es) | Compuestos, composición y uso de los mismos como moduladores de la expresión de pcsk9. (divisional solicitud 201902574) | |
| CL2008003405A1 (es) | Compuestos derivados de tienopiridina, inhibidores de la enzima integrasa del vih; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion por vih. | |
| EP2513343A4 (en) | METHOD AND COMPOSITIONS FOR TREATING SKIN INFLAMMATION | |
| JOP20210269A1 (ar) | تركيبة دوائية مائية لجسم مضاد ضد-il17a واستخدامها | |
| CO2021008816A2 (es) | Moduladores de trex1 | |
| MX2022008478A (es) | Combinaciones de brimonidina de dosis baja y usos de las mismas. | |
| CL2017002214A1 (es) | Formulación de combinación de tesofensina y betabloqueante | |
| CL2011003327A1 (es) | Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales. | |
| SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
| CO2022000266A2 (es) | Inhibidores de enzimas | |
| MX2017009482A (es) | Formulación farmacéutica. | |
| CO2022000270A2 (es) | Inhibidores de enzimas | |
| ECSP23053033A (es) | N-(2-(4-cianotiazolidin-3-il)-2-oxoetil)-quinolin-4-carboxamidas | |
| MX2023011498A (es) | Toallita topica que contiene nifedipina y lidocaina. |